These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

645 related articles for article (PubMed ID: 18674538)

  • 21. CD4+ T cell mediated intestinal immunity: chronic inflammation versus immune regulation.
    Westendorf AM; Templin M; Geffers R; Deppenmeier S; Gruber AD; Probst-Kepper M; Hansen W; Liblau RS; Gunzer F; Bruder D; Buer J
    Gut; 2005 Jan; 54(1):60-9. PubMed ID: 15591505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role and potential therapeutic application of myeloid-derived suppressor cells in TNBS-induced colitis.
    Guan Q; Moreno S; Qing G; Weiss CR; Lu L; Bernstein CN; Warrington RJ; Ma Y; Peng Z
    J Leukoc Biol; 2013 Oct; 94(4):803-11. PubMed ID: 23901119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Areca nut extracts enhance the development of CD11b(+) Gr-1(+) cells with the characteristics of myeloid-derived suppressor cells in antigen-stimulated mice.
    Wang CC; Lin HL; Liang HJ; Jan TR
    J Oral Pathol Med; 2011 Nov; 40(10):769-77. PubMed ID: 21481006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myeloid derived suppressor cells and their role in tolerance induction in cancer.
    Fujimura T; Mahnke K; Enk AH
    J Dermatol Sci; 2010 Jul; 59(1):1-6. PubMed ID: 20570112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vasoactive intestinal peptide induces CD14+HLA-DR‑/low myeloid-derived suppressor cells in gastric cancer.
    Li G; Wu K; Tao K; Lu X; Ma J; Mao Z; Li H; Shi L; Li J; Niu Y; Xiang F; Wang G
    Mol Med Rep; 2015 Jul; 12(1):760-8. PubMed ID: 25695487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells.
    Marigo I; Dolcetti L; Serafini P; Zanovello P; Bronte V
    Immunol Rev; 2008 Apr; 222():162-79. PubMed ID: 18364001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myeloid-derived suppressor cell functionality and interaction with Leishmania major parasites differ in C57BL/6 and BALB/c mice.
    Schmid M; Zimara N; Wege AK; Ritter U
    Eur J Immunol; 2014 Nov; 44(11):3295-306. PubMed ID: 25142017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SSC(high)CD11b(high)Ly-6C(high)Ly-6G(low) myeloid cells curtail CD4 T cell response by inducible nitric oxide synthase in murine hepatitis.
    Zhu K; Zhang N; Guo N; Yang J; Wang J; Yang C; Yang C; Zhu L; Xu C; Deng Q; Zhu R; Wang H; Chen X; Shi Y; Li Y; Leng Q
    Int J Biochem Cell Biol; 2014 Sep; 54():89-97. PubMed ID: 25035167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events.
    Schouppe E; Mommer C; Movahedi K; Laoui D; Morias Y; Gysemans C; Luyckx A; De Baetselier P; Van Ginderachter JA
    Eur J Immunol; 2013 Nov; 43(11):2930-42. PubMed ID: 23878002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased arthritis susceptibility in cartilage proteoglycan-specific T cell receptor-transgenic mice.
    Berlo SE; Guichelaar T; Ten Brink CB; van Kooten PJ; Hauet-Broeren F; Ludanyi K; van Eden W; Broeren CP; Glant TT
    Arthritis Rheum; 2006 Aug; 54(8):2423-33. PubMed ID: 16869010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor-infiltrating myeloid-derived suppressor cells are pleiotropic-inflamed monocytes/macrophages that bear M1- and M2-type characteristics.
    Umemura N; Saio M; Suwa T; Kitoh Y; Bai J; Nonaka K; Ouyang GF; Okada M; Balazs M; Adany R; Shibata T; Takami T
    J Leukoc Biol; 2008 May; 83(5):1136-44. PubMed ID: 18285406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abortive activation precedes functional deletion of CD8+ T cells following encounter with self-antigens expressed by resting B cells in vivo.
    Fraser JM; Janicki CN; Raveney BJ; Morgan DJ
    Immunology; 2006 Sep; 119(1):126-33. PubMed ID: 16796693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IFN-γ producing T cells contribute to the increase of myeloid derived suppressor cells in tumor-bearing mice after cyclophosphamide treatment.
    Guo Q; Lv Z; Fu Q; Jiang C; Liu Y; Lai L; Chen Q; Shen J; Wang Q
    Int Immunopharmacol; 2012 Feb; 12(2):425-32. PubMed ID: 22226750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Redirection of regulatory T cells with predetermined specificity for the treatment of experimental colitis in mice.
    Elinav E; Waks T; Eshhar Z
    Gastroenterology; 2008 Jun; 134(7):2014-24. PubMed ID: 18424268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-15 is critical for the maintenance and innate functions of self-specific CD8(+) T cells.
    Itsumi M; Yoshikai Y; Yamada H
    Eur J Immunol; 2009 Jul; 39(7):1784-93. PubMed ID: 19544306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of myeloid-derived suppressor cells and T regulatory cells in lung microenvironment after Urethane-induced lung tumor.
    Rosin FC; Pedregosa JF; de Almeida JS; Bueno V
    Int Immunopharmacol; 2011 Jul; 11(7):873-8. PubMed ID: 21238620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Depletion of regulatory T cells facilitates growth of established tumors: a mechanism involving the regulation of myeloid-derived suppressor cells by lipoxin A4.
    Zhang B; Jia H; Liu J; Yang Z; Jiang T; Tang K; Li D; Huang C; Ma J; Shen GX; Ye D; Huang B
    J Immunol; 2010 Dec; 185(12):7199-206. PubMed ID: 21068404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CpG motifs of bacterial DNA exert protective effects in mouse models of IBD by antigen-independent tolerance induction.
    Bleich A; Janus LM; Smoczek A; Westendorf AM; Strauch U; Mähler M; Hedrich HJ; Fichtner-Feigl S; Schölmerich J; Falk W; Hofmann C; Obermeier F
    Gastroenterology; 2009 Jan; 136(1):278-87. PubMed ID: 18952084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth.
    Schlecker E; Stojanovic A; Eisen C; Quack C; Falk CS; Umansky V; Cerwenka A
    J Immunol; 2012 Dec; 189(12):5602-11. PubMed ID: 23152559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myeloid-derived suppressor cell heterogeneity and subset definition.
    Peranzoni E; Zilio S; Marigo I; Dolcetti L; Zanovello P; Mandruzzato S; Bronte V
    Curr Opin Immunol; 2010 Apr; 22(2):238-44. PubMed ID: 20171075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.